CCRM Colorado is conducting a clinical research study of natural antioxidant supplementation (OvaHealth) prior to infertility treatment.

The aim of this study is to improve ovarian function for 8-12 weeks prior to an in vitro fertilization (IVF) cycle for women with a history of failed implantation.

Ongoing data reported by CCRM in September 2016 has shown significant improvements in clinical outcomes for participants that took the OvaHealth™ supplements for 8-12 weeks prior to their IVF cycle, including higher number of eggs and fertilized embryos.  Following 138 frozen embryo transfers with chromosomally normal blastocyst OvaHealth study patients have an 80% ongoing clinical pregnancy and live birth rate.

Please note that even though it is possible to purchase anti-oxidant supplements and products in pharmacies and supermarkets, our OvaHealth Supplement is unique! It is produced in a way to preserve the berry’s natural high level of anti-oxidant activity that we measure by biochemical analysis.

Study Criteria

Patients must meet all of the requirements and be committed to participation in the program at CCRM Colorado.

Female patients will also need to have:

• At least one previous failed cycle at CCRM or elsewhere
• Maternal age ≤44 years old
• Female patient must be willing to take OvaHealth supplement for 8-12 weeks prior to IVF cycle
• Sufficient sperm for ICSI
• Preference for an upcoming CCS cycle

Additional screening will be conducted to determine if you are eligible to participate. Those who qualify and participate in the study will receive the exclusive natural antioxidant supplementation for a nominal fee. Regular IVF and CCS fees still apply.

For more information, call (303) 788-8300 and ask for Lindsey M., clinical research coordinator or email ovahealthstudy@colocrm.com.